Ocular (eye) redness is an extremely common condition that can be caused by minor irritations. Researchers are working on a new therapy to better relieve eye redness.
Alcon is assessing the safety and efficacy of a new topical (eye drop) medication for reducing ocular redness caused by minor eye irritations in adults. This investigational eye drop was previously studied and showed potential for both fast and long-lasting redness relief. It may even provide up to 12 hours of redness relief, starting within 1 minute. Researchers hope this new therapy can prove to be both safe and effective, allowing patients with ocular redness to experience longer lasting relief without the hassle of frequently using eye drops.
This study is evaluating the preservative free version of the investigational medication. Participants will be given eye drops to take home and dose twice a day, 12 hours apart. This study will require participants to use an electronic diary, on a personal device (with internet access), to record when the study eye drops are used at home between visits, for about eight weeks.
There are a total of six visits over approximately 10 weeks, where participants will come into a clinic and undergo several non-invasive eye exams and questionnaires. Participants may also receive compensation of up to $XXX for their time and effort.
To see if you qualify, complete the form below. Our team will reach out to ask a few questions and provide more details.
You may qualify to participate if you:
Are 18 years or older
Have used or wanted to use eye drops for ocular redness relief in the last six months.
Have NOT had eye surgery in the past six months
Have no major ocular conditions other than ocular redness
If you qualify for this study, here is what you can expect:
During this visit you will go through a series of assessments, including:
The study team will go over all assessments with you in detail during your visits.
We are currently conducting this study nationwide. Check out our clinic locations below to find out if we have a study site near you.
Add Your Tooltip Text Here
Add Your Tooltip Text Here
Add Your Tooltip Text Here
Add Your Tooltip Text Here
Add Your Tooltip Text Here
The study will last approximately 10 weeks (~70 days) and include six (6) clinic visits.
No. You must be a reasonably healthy person with no active ocular infections or other major eye conditions like dry eye disease or eye allergies. You will be assessed and scored based on your eye redness. If you commonly experience ocular redness, you may be eligible to participate in this study.
Taking part in any clinical study is entirely voluntary. Your decision whether to participate will not affect the medical care you currently receive or may receive in the future. If you qualify and choose to join the study, you may withdraw at any time and for any reason.
All study-related testing will be provided to you by the sponsor at no charge; Any tests and procedures that are routine care for your eye condition (not part of this research study) may be billed to your insurance.
Your personal and medical information is completely protected before, during and after the clinical trial process through the HIPAA (Health Insurance Portability and Accountability Act) Privacy Rule. You will also be informed of who has access to your personal information.
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.